Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg

Author
Shestakova, M. V.
Satman, I.
Piletic, M.
Leiter, L. A.
Trubitsyna, N. P.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/33493
Collections